Congress should give the Food and Drug Administration (FDA) more power to help prevent, alleviate, and resolve drug shortages, according to the Government Accountability Office (GAO). The recommendation came in a report presented during a December 15 hearing by the Senate Committee on Health, Education, Labor, and Pensions.
In the report, the GAO indicated that even though the FDA has a drug shortage program, the agency is constrained in its ability to prevent shortages because it lacks the authority to require manufacturers to report actual or potential shortages or take actions to mitigate shortage situations (http://tinyurl.com/cc5t5ju).
Mitka M. FDA and Drug Shortages. JAMA. 2012;307(6):553. doi:10.1001/jama.2012.89
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: